{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:22:43Z","timestamp":1791354163857,"version":"4.3.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.cmi.2017.05.028","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T07:45:53Z","timestamp":1497599153000},"page":"37-42","source":"Crossref","is-referenced-by-count":61,"title":["Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions"],"prefix":"10.1016","volume":"24","author":[{"given":"E.R.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.E.","family":"Nabarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hedley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.L.","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2017.05.028_bib1","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1586\/14787210.2014.942283","article-title":"Management of chronic Giardia infection","volume":"12","author":"Escobedo","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cmi.2017.05.028_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mib.2016.07.019","article-title":"An update on Giardia and giardiasis","volume":"34","author":"Einarsson","year":"2016","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.cmi.2017.05.028_bib3","first-page":"599","article-title":"Prevalence of malnutrition and intestinal parasites in preschool slum children in Lucknow","volume":"34","author":"Awasthi","year":"1997","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.cmi.2017.05.028_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/0255-0857.142236","article-title":"Refractory giardiasis: a molecular appraisal from a tertiary care centre in India","volume":"32","author":"Yadav","year":"2014","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.cmi.2017.05.028_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2105\/AJPH.79.4.485","article-title":"Recurrent outbreaks of giardiasis in a child day care center, Wisconsin","volume":"79","author":"Steketee","year":"1989","journal-title":"Am J Public Health"},{"key":"10.1016\/j.cmi.2017.05.028_bib6","first-page":"79","article-title":"Molecular characterisation of Giardia isolates from clinical infections following a waterborne outbreak","volume":"55","author":"Robertson","year":"2007","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2017.05.028_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CMR.14.1.114-128.2001","article-title":"Treatment of giardiasis","volume":"14","author":"Gardner","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2017.05.028_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00006454-200102000-00015","article-title":"Treatment of Giardia lamblia infections","volume":"20","author":"Nash","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2017.05.028_bib9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/AAC.00909-08","article-title":"Giardia, Entamoeba, and Trichomonas enzymes activate metronidazole (nitroreductases) and inactivate metronidazole (nitroimidazole reductases)","volume":"53","author":"Pal","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0020-7519(90)90196-T","article-title":"Drug resistance in Giardia intestinalis","volume":"20","author":"Upcroft","year":"1990","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.cmi.2017.05.028_bib11","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1128\/AAC.00384-11","article-title":"Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia","volume":"55","author":"Tejman-Yarden","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jac\/dkg150","article-title":"Isolation, excystation and axenization of Giardia lamblia isolates: in\u00a0vitro susceptibility to metronidazole and albendazole","volume":"51","author":"Cruz","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.actatropica.2016.06.026","article-title":"Combination therapy in the management of giardiasis: what laboratory and clinical studies tell us, so far","volume":"162","author":"Escobedo","year":"2016","journal-title":"Acta Trop"},{"key":"10.1016\/j.cmi.2017.05.028_bib14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cmi.2015.04.019","article-title":"Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London, 2008\u20132013","volume":"21","author":"Nabarro","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.05.028_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1086\/320886","article-title":"Treatment of patients with refractory giardiasis","volume":"33","author":"Nash","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.05.028_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0016-5085(82)80008-5","article-title":"Chronic giardiasis: studies on drug sensitivity, toxin production, and host immune response","volume":"83","author":"Smith","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmi.2017.05.028_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/jac\/8.4.305","article-title":"Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine, and other antimicrobial agents","volume":"8","author":"Gillin","year":"1981","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib18","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/AAC.43.7.1533","article-title":"Why metronidazole is active against both bacteria and parasites","volume":"43","author":"Samuelson","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpddr.2016.07.003","article-title":"Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target","volume":"6","author":"Leitsch","year":"2016","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.cmi.2017.05.028_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.gene.2013.11.048","article-title":"Differential gene expression in Giardia lamblia under oxidative stress: significance in eukaryotic evolution","volume":"535","author":"Raj","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.cmi.2017.05.028_bib21","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/jac\/dkr192","article-title":"Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia","volume":"66","author":"Leitsch","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib22","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.meegid.2009.05.015","article-title":"In\u00a0vitro resistance to 5-nitroimidazoles and benzimidazoles in Giardia duodenalis: variability and variation in gene expression","volume":"9","author":"Arguello-Garcia","year":"2009","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.cmi.2017.05.028_bib23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3855\/jidc.5768","article-title":"Determination of PFOR gene expression in strains of G.\u00a0intestinalis with different inhibitory concentrations of metronidazole","volume":"9","author":"Begaydarova","year":"2015","journal-title":"J\u00a0Infect Dev Ctries"},{"key":"10.1016\/j.cmi.2017.05.028_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tmaid.2012.10.004","article-title":"Refractory giardiasis in Spanish travellers","volume":"11","author":"Munoz Gutierrez","year":"2013","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.cmi.2017.05.028_bib25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/jac\/dkh388","article-title":"Variability and variation in drug susceptibility among Giardia duodenalis isolates and clones exposed to 5-nitroimidazoles and benzimidazoles in\u00a0vitro","volume":"54","author":"Arguello-Garcia","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib26","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3389\/fmicb.2015.00800","article-title":"Albendazole induces oxidative stress and DNA damage in the parasitic protozoan Giardia duodenalis","volume":"6","author":"Martinez-Espinosa","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2017.05.028_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4269\/ajtmh.2010.09-0742","article-title":"Short course combination therapy for giardiasis after nitroimidazole failure","volume":"83","author":"Lopez-Velez","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2017.05.028_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/mdr.1996.2.433","article-title":"Induction of albendazole resistance in Giardia lamblia","volume":"2","author":"Lindquist","year":"1996","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.cmi.2017.05.028_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/mdr.1996.2.303","article-title":"Albendazole resistance in Giardia is correlated with cytoskeletal changes but not with a mutation at amino acid 200 in beta-tubulin","volume":"2","author":"Upcroft","year":"1996","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.cmi.2017.05.028_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1368-7646(98)80035-6","article-title":"Drug resistance in Giardia: clinical versus laboratory isolates","volume":"1","author":"Upcroft","year":"1998","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.cmi.2017.05.028_bib31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.apjtm.2016.07.013","article-title":"Introducing nitazoxanide as a promising alternative treatment for symptomatic to metronidazole-resistant giardiasis in clinical isolates","volume":"9","author":"Galeh","year":"2016","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.cmi.2017.05.028_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s40475-015-0051-1","article-title":"Drug resistance in the microaerophilic parasite Giardia lamblia","volume":"2","author":"Leitsch","year":"2015","journal-title":"Curr Trop Med Rep"},{"key":"10.1016\/j.cmi.2017.05.028_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1432-1033.1996.0155t.x","article-title":"A\u00a0H2O-producing NADH oxidase from the protozoan parasite Giardia duodenalis","volume":"241","author":"Brown","year":"1996","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.cmi.2017.05.028_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/00365528909091335","article-title":"Furazolidone and metronidazole for treatment of giardiasis in children","volume":"169","author":"Quiros-Buelna","year":"1989","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.cmi.2017.05.028_bib35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/46.5.819","article-title":"Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France","volume":"46","author":"Lemee","year":"2000","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00436-009-1363-7","article-title":"Changes in beta-giardin sequence of Giardia intestinalis sensitive and resistant to albendazole strains","volume":"105","author":"Jimenez-Cardoso","year":"2009","journal-title":"Parasitol Res"},{"key":"10.1016\/j.cmi.2017.05.028_bib37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/AAC.50.1.162-170.2006","article-title":"In\u00a0vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells","volume":"50","author":"Muller","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib38","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/AAC.01159-06","article-title":"Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni","volume":"51","author":"Hoffman","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1179\/000349803235002290","article-title":"Comparison of chloroquine, albendazole and tinidazole in the treatment of children with giardiasis","volume":"97","author":"Escobedo","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.cmi.2017.05.028_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/AAC.28.3.378","article-title":"In\u00a0vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents","volume":"28","author":"Gordts","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib41","first-page":"607","article-title":"A\u00a0randomized, controlled, open-label trial evaluating the efficacy and safety of chloroquine in the treatment of giardiasis in children","volume":"59","author":"Canete","year":"2010","journal-title":"West Indian Med J"},{"key":"10.1016\/j.cmi.2017.05.028_bib42","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/jac\/dkr029","article-title":"Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs","volume":"66","author":"Nillius","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib43","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1086\/320751","article-title":"Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome","volume":"32","author":"Abboud","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.05.028_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.molbiopara.2015.01.005","article-title":"The effect of metronidazole on the cell cycle and DNA in metronidazole-susceptible and -resistant Giardia cell lines","volume":"198","author":"Uzlikova","year":"2014","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.cmi.2017.05.028_bib45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/CMR.14.1.150-164.2001","article-title":"Drug targets and mechanisms of resistance in the anaerobic protozoa","volume":"14","author":"Upcroft","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2017.05.028_bib46","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0020-7519(94)00174-M","article-title":"In\u00a0vitro drug susceptibility of 29 isolates of Giardia duodenalis from humans as assessed by an adhesion assay","volume":"25","author":"Farbey","year":"1995","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.cmi.2017.05.028_bib47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1432-1033.1994.tb18641.x","article-title":"A\u00a0purified ferredoxin from Giardia duodenalis","volume":"220","author":"Townson","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.cmi.2017.05.028_bib48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jac\/dkn142","article-title":"Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole","volume":"62","author":"Muller","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib49","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2958.2009.06675.x","article-title":"Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance","volume":"72","author":"Leitsch","year":"2009","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.cmi.2017.05.028_bib50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0166-6851(96)02661-8","article-title":"Characterisation and purification of pyruvate:ferredoxin oxidoreductase from Giardia duodenalis","volume":"79","author":"Townson","year":"1996","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.cmi.2017.05.028_bib51","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/jac\/dkt106","article-title":"Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2)","volume":"68","author":"Muller","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.meegid.2012.08.021","article-title":"Proteomic and transcriptional analyses of genes differentially expressed in Giardia duodenalis clones resistant to albendazole","volume":"15","author":"Paz-Maldonado","year":"2013","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.cmi.2017.05.028_bib53","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3748\/wjg.v10.i8.1215","article-title":"Albendazole versus metronidazole treatment of adult giardiasis: an open randomized clinical study","volume":"10","author":"Karabay","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cmi.2017.05.028_bib54","first-page":"761","article-title":"[Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis]","volume":"146","author":"Cacopardo","year":"1995","journal-title":"Clin Ter"},{"key":"10.1016\/j.cmi.2017.05.028_bib55","first-page":"268","article-title":"Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway","volume":"56","author":"Morch","year":"2008","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2017.05.028_bib56","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1550-7408.2002.tb00523.x","article-title":"In\u00a0vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites","volume":"49","author":"Cedillo-Rivera","year":"2002","journal-title":"J\u00a0Eukaryot Microbiol"},{"key":"10.1016\/j.cmi.2017.05.028_bib57","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1517\/14656566.8.12.1885","article-title":"Giardiasis: a pharmacotherapy review","volume":"8","author":"Escobedo","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cmi.2017.05.028_bib58","first-page":"122","article-title":"[Effectiveness and safety of mebendazole compared to nitazoxanide in the treatment of Giardia lamblia in children]","volume":"64","author":"Rodriguez-Garcia","year":"1999","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.cmi.2017.05.028_bib59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/49.1.103","article-title":"In\u00a0vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis","volume":"49","author":"Adagu","year":"2002","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.exppara.2005.12.009","article-title":"The effects of metronidazole and furazolidone during Giardia differentiation into cysts","volume":"113","author":"Hausen","year":"2006","journal-title":"Exp Parasitol"},{"issue":"Pt 3","key":"10.1016\/j.cmi.2017.05.028_bib61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0031182000065823","article-title":"Quinacrine-resistant Giardia duodenalis","volume":"112","author":"Upcroft","year":"1996","journal-title":"Parasitology"},{"key":"10.1016\/j.cmi.2017.05.028_bib62","first-page":"79","article-title":"Giardia lamblia: in-vitro sensitivity to some chemotherapeutic agents","volume":"30","author":"Baveja","year":"1998","journal-title":"J\u00a0Commun Dis"},{"key":"10.1016\/j.cmi.2017.05.028_bib63","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1128\/AAC.37.12.2668","article-title":"Structure-activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition","volume":"37","author":"Bell","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib64","first-page":"15","article-title":"The treatment of Giardia lamblia infection with mepacrine, metronidazole and furazolidone","volume":"73","author":"Bassily","year":"1970","journal-title":"J\u00a0Trop Med Hyg"},{"key":"10.1016\/j.cmi.2017.05.028_bib65","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/archpedi.1981.02130260056016","article-title":"Furazolidone and quinacrine. Comparative study of therapy for giardiasis in children","volume":"135","author":"Craft","year":"1981","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.cmi.2017.05.028_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.02.2012.5842","article-title":"Quinacrine induced mood disturbance \u2013 the unmasking of bipolar affective disorder","author":"Lally","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.cmi.2017.05.028_bib67","first-page":"63","article-title":"Toxic psychosis following Atabrine","volume":"86","author":"Gaskill","year":"1945","journal-title":"Bull US Army Med Dept"},{"key":"10.1016\/j.cmi.2017.05.028_bib68","doi-asserted-by":"crossref","first-page":"O135","DOI":"10.1111\/1469-0691.12327","article-title":"A\u00a0family cluster of giardiasis with variable treatment responses: refractory giardiasis in a family after a trip to India","volume":"20","author":"Requena-Mendez","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.05.028_bib69","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0002-9378(81)90082-X","article-title":"Giardiasis in pregnancy","volume":"140","author":"Kreutner","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cmi.2017.05.028_bib70","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3201\/eid2010.140073","article-title":"Treatment of giardiasis after nonresponse to nitroimidazole","volume":"20","author":"Meltzer","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2017.05.028_bib71","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4269\/ajtmh.1995.52.318","article-title":"Chemotherapy for giardiasis: randomized clinical trial of bacitracin, bacitracin zinc, and a combination of bacitracin zinc with neomycin","volume":"52","author":"Andrews","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2017.05.028_bib72","first-page":"358","article-title":"Selective immunoglobulin M deficiency in a patient with refractory giardiasis","volume":"20","author":"Kampitak","year":"2010","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.cmi.2017.05.028_bib73","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01947-16","article-title":"Phase I clinical trial results of auranofin, a novel antiparasitic agent","volume":"61","author":"Capparelli","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.43.1.73","article-title":"Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp","volume":"43","author":"Upcroft","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.05.028_bib75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijantimicag.2010.03.004","article-title":"A\u00a0new-generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in\u00a0vitro","volume":"36","author":"Dunn","year":"2010","journal-title":"Int J Antimicrob Agents"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17302896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17302896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T08:13:29Z","timestamp":1602317609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X17302896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1198743X17302896"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2017.05.028","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}